Cargando…

Gene Editing, Gene Therapy, and Cell Xenotransplantation: Cell Transplantation Across Species

PURPOSE OF REVIEW: Cell xenotransplantation has the potential to provide a safe, ethically acceptable, unlimited source for cell replacement therapies. This review focuses on genetic modification strategies aimed to overcome remaining hurdles standing in the way of clinical porcine islet transplanta...

Descripción completa

Detalles Bibliográficos
Autores principales: Mourad, Nizar I., Gianello, Pierre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577055/
https://www.ncbi.nlm.nih.gov/pubmed/28932650
http://dx.doi.org/10.1007/s40472-017-0157-6
_version_ 1783260273289723904
author Mourad, Nizar I.
Gianello, Pierre
author_facet Mourad, Nizar I.
Gianello, Pierre
author_sort Mourad, Nizar I.
collection PubMed
description PURPOSE OF REVIEW: Cell xenotransplantation has the potential to provide a safe, ethically acceptable, unlimited source for cell replacement therapies. This review focuses on genetic modification strategies aimed to overcome remaining hurdles standing in the way of clinical porcine islet transplantation and to develop neural cell xenotransplantation. RECENT FINDINGS: In addition to previously described genetic modifications aimed to mitigate hyperacute rejection, instant blood-mediated inflammatory reaction, and cell-mediated rejection, new data showing the possibility of increasing porcine islet insulin secretion by transgenesis is an interesting addition to the array of genetically modified pigs available for xenotransplantation. Moreover, combining multiple modifications is possible today thanks to new, improved genomic editing tools. SUMMARY: Genetic modification of large animals, pigs in particular, has come a long way during the last decade. These modifications can help minimize immunological and physiological incompatibilities between porcine and human cells, thus allowing for better tolerance and function of xenocells.
format Online
Article
Text
id pubmed-5577055
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-55770552017-09-18 Gene Editing, Gene Therapy, and Cell Xenotransplantation: Cell Transplantation Across Species Mourad, Nizar I. Gianello, Pierre Curr Transplant Rep Cellular Transplants (G Orlando, Section Editor) PURPOSE OF REVIEW: Cell xenotransplantation has the potential to provide a safe, ethically acceptable, unlimited source for cell replacement therapies. This review focuses on genetic modification strategies aimed to overcome remaining hurdles standing in the way of clinical porcine islet transplantation and to develop neural cell xenotransplantation. RECENT FINDINGS: In addition to previously described genetic modifications aimed to mitigate hyperacute rejection, instant blood-mediated inflammatory reaction, and cell-mediated rejection, new data showing the possibility of increasing porcine islet insulin secretion by transgenesis is an interesting addition to the array of genetically modified pigs available for xenotransplantation. Moreover, combining multiple modifications is possible today thanks to new, improved genomic editing tools. SUMMARY: Genetic modification of large animals, pigs in particular, has come a long way during the last decade. These modifications can help minimize immunological and physiological incompatibilities between porcine and human cells, thus allowing for better tolerance and function of xenocells. Springer International Publishing 2017-07-21 2017 /pmc/articles/PMC5577055/ /pubmed/28932650 http://dx.doi.org/10.1007/s40472-017-0157-6 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Cellular Transplants (G Orlando, Section Editor)
Mourad, Nizar I.
Gianello, Pierre
Gene Editing, Gene Therapy, and Cell Xenotransplantation: Cell Transplantation Across Species
title Gene Editing, Gene Therapy, and Cell Xenotransplantation: Cell Transplantation Across Species
title_full Gene Editing, Gene Therapy, and Cell Xenotransplantation: Cell Transplantation Across Species
title_fullStr Gene Editing, Gene Therapy, and Cell Xenotransplantation: Cell Transplantation Across Species
title_full_unstemmed Gene Editing, Gene Therapy, and Cell Xenotransplantation: Cell Transplantation Across Species
title_short Gene Editing, Gene Therapy, and Cell Xenotransplantation: Cell Transplantation Across Species
title_sort gene editing, gene therapy, and cell xenotransplantation: cell transplantation across species
topic Cellular Transplants (G Orlando, Section Editor)
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5577055/
https://www.ncbi.nlm.nih.gov/pubmed/28932650
http://dx.doi.org/10.1007/s40472-017-0157-6
work_keys_str_mv AT mouradnizari geneeditinggenetherapyandcellxenotransplantationcelltransplantationacrossspecies
AT gianellopierre geneeditinggenetherapyandcellxenotransplantationcelltransplantationacrossspecies